Early research (Phase 1)Study completedNCT04507256What this trial is testingAZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19Who this might be right forCOVID-19 AstraZeneca 60
Not applicableUnknownNCT04408339What this trial is testingCOVID-19 in Cancer Patients: Evaluation of Clinical Course and Impact on Oncological Care Including BiobankingWho this might be right forCancerCOVID Universitätsklinikum Hamburg-Eppendorf 500
Not applicableStudy completedNCT04669054What this trial is testingHospital Interns Psychological State During the COVID-19Who this might be right forCOVID 19DepressionStress Disorders, Post-Traumatic University Hospital, Montpellier 102
Not applicableStudy completedNCT05598957What this trial is testingEvaluation of the Relationship of Vitamin D and Vitamin D Binding Protein With Disease Severity in Pediatric Sars-CoV2Who this might be right forSARS CoV-2 Infection Marmara University 82
Not applicableStudy completedNCT04631172What this trial is testingCovid-19 Anxiety and Phobia Levels of the ParentsWho this might be right forSARS-CoV-2Anxiety and FearParents Selcuk University 150
Not applicableStudy completedNCT04647734What this trial is testingThe Protective Potential of Exercise Training on the Cardiopulmonary Morbidity After COVID-19Who this might be right forCOVID-19, SARS-CoV2 Rigshospitalet, Denmark 28
Testing effectiveness (Phase 2)Study completedNCT05576623What this trial is testingSafety and Immunogenicity of AdCLD-CoV19-1 OMI as a Booster: A SARS-CoV-2 (COVID-19) Preventive VaccineWho this might be right forCOVID-19Vaccines Cellid Co., Ltd. 320
Not applicableActive Not RecruitingNCT06204458What this trial is testingMild Water-filtered Infrared-A Whole-body Hyperthermia in Patients With Post-COVID Syndrome (HyPoCo)Who this might be right forPost-COVID Syndrome Universität Duisburg-Essen 60
Large-scale testing (Phase 3)WithdrawnNCT05157243What this trial is testingTrial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe IllnessWho this might be right forCOVID-19 Romark Laboratories L.C.
Not applicableUnknownNCT04719208What this trial is testing[COVID-19] Reduction of Sars-CoV-2 Oral Viral Load With Prophylactic Mouth RinseWho this might be right forCovid19 Augusta University 60
Early research (Phase 1)UnknownNCT04619290What this trial is testingOutpatient Treatment With CoVid-19 With PrexabluWho this might be right forSars Cov 2 Hospital Reg. Lic. Adolfo Lopez Mateos 46
Post-approval studies (Phase 4)Study completedNCT05080218What this trial is testingCOVID-19 VaccinE Response in Rheumatology PatientsWho this might be right forRheumatoid ArthritisPsoriatic ArthritisSpondylarthritis Jeffrey Curtis 841
Not applicableStudy completedNCT04905823What this trial is testingEffect of SARSCoV2 (COVID-19) Vaccination in Type 1 Diabetes (CoVaxT1D)Who this might be right forType 1 Diabetes Paolo Fiorina, MD 600
Testing effectiveness (Phase 2)Study completedNCT05205096What this trial is testingImmunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVacWho this might be right forCOVID-19 Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 480
Not applicableStudy completedNCT04810117What this trial is testingMonitoring the IgG/IgM Antibodies in COVID-19 PatientsWho this might be right forCOVID-19 Infections University of Sargodha 373
Not applicableStudy completedNCT05054218What this trial is testingCOVID-19 Immunogenicity of a Third Dose of mRNA-1273 Vaccine Among Cancer PatientsWho this might be right forCovid19SARS-CoV2 Infection H. Lee Moffitt Cancer Center and Research Institute 336
Testing effectiveness (Phase 2)Ended earlyNCT05122182What this trial is testingControlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19Who this might be right forCOVID-19SARS-CoV2 Infection University of Sydney 49
Not applicableStudy completedNCT05293379What this trial is testingProspective, Multicenter Study Assessing a Screening Campaign for Cardiovascular Diseases Risk Factors During SARS-CoV-2 EpidemicWho this might be right forHealth BehaviorCardiovascular DiseasesCardiovascular Morbidity Elsan 2,400
Not applicableEnded earlyNCT05142540What this trial is testingDetection and Characterization of Anti-SARS-CoV-2 Salivary Antibodies After COVID-19 Booster VaccinesWho this might be right forAnti-SARS-CoV-2 Antibody Response Medical University of Graz 140
Early research (Phase 1)WithdrawnNCT04371640What this trial is testingSirolimus in COVID-19 Phase 1Who this might be right forSARS-CoV-2Covid-19 Walter K. Kraft